Quinagolide is a D2 dopamine receptor agonist which may be used to treat hyperprolactinaemia.
Quinagolide is as effective as bromocriptine in reducing prolactin levels and is as well tolerated as once-daily bromocriptine.
Quinagolide is more expensive than the other dopmaine receptor agonists and is probably worth considering only in patients resistant to bromocriptine and cabergoline (1).
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.